1[1]Paster JC. Proliferative vitreoretinopathy: An overview[J].Surv Ophthalmol, 1998,43:3-18.
2[2]Diddie KR. Anterior proliferative vitreoretinopathy in the silicone study. Silicone study report number 10[J]. Ophthalmology, 1996, 103:1092-1099.
3[3]Schubert HD. Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous[J].Surv Ophthalmol, 1996, 41:97-125.
4[6]Russell KR, Wang DR, Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist[J]. Exp Eye Res, 2000,70: 675-682.
5[7]Rossier A, Uffer S, Mermoud A. Aqueous dynamics in experimental ab externo trabeculectomy [J]. Ophthalmic Res,2000,32:165-171.
6[8]Takashima Y, Taniguchi T, Yoshida M, et al. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide[J]. Exp Eye Res, 1998,66:89-96.
7[2]Toris CB,Pederson JE. Effect of intraocular pressure on uveocsleral outflow following cyclodialysis in the monkey eye. Invest Ophthalmol Vis Sci,1985,6:1745
8[4]Russell KR,Wang DR,Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine,a kappa opioid receptor agonist. Exp Eye Res,2000,0:675
9[5]Rossier A,Uffer S,Mermoud A. Aqueous dynamics in experimental ab externo trabeculectomy. Ophthalmic Res,2000,2:165
10[6]Takashima Y,Taniguchi T,Yoshida M et al. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. Exp Eye Res,1998,66:89
